The Phase 1 trial of the second-generation triterpenoid antifungal SCY-247, initiated in December of 2024, continues and results are expected in ...

The firm's Italian distributor A.D.A. is beginning a four-hospital study in collaboration with the Italian Society for Clinical Microbiology to evaluate the system.

The following is a summary of “Feasibility of antimicrobial lead time as process and quality indicator for hospitals,” ...

In response to this season’s high flu activity and the ongoing avian flu outbreaks, the Centers for Disease Control and Prevention (CDC) has advised clinicians and laboratories to conduct subtype ...

Eric Siegel, a Ph.D. student in microbiologist Stephen Rich’s Laboratory of Medical Zoology and at the UMass Amherst-based New England Center of Excellence in Vector-borne Diseases (NEWVEC), has been ...

Five years after Donald Trump declared a national COVID emergency, here's what the research says about face masks.

The Faculty of Medicine offers training in clinical genetics, clinical chemistry and clinical microbiology either as part of a Licentiate of Philosophy degree or separately after completing an ...

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

Researchers have worked with global partners to identify and successfully implement an intervention package that has significantly improved the diagnosis and management of brain infections in ...

Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid ...